910463-68-2
C187H291N45O59
4113.57754
99% min (HPLC)
White powder
Antidiabetic, anti-obesity
Semaglutide
GLP-1
N
DMF
2022
PIC/S GMP (China, US and Europe)
Availability: | |
---|---|
Supply Chain
As of August 20, 2024, there are 226 potential suppliers manufacturing Semaglutide API (CAS No. 910463-68-2), including 186 traders, 40 factories and 29 labs, among which:
- The 25th percentile has an average registered capital of 1 million CNY;
- The 50th percentile has an average registerd capital of 3 million CNY;
- The 75th percentile has an average registered capital of 8 million CNY.
Feeling overwhelmed? Contact Unibest if you need us to quality-check other sources to strengthen your supply chain or to find a tailored solution for your specific procurement request.
Read more about how Unibest select API sources here.
About the Manufacturer We Recommended
This manufacturer we recommend strictly follows GMP standard, and has 32 laboratories, 5 API production lines, and 6 injection production line. The Semaglutide API source is produced from fermentation.
In 2023, the PFS & Cartridge injection line was inspected by US FDA. And the Semaglutide API has been put into tablets production in Laos.